QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, today reported preliminary, unaudited net sales results for its fiscal fourth quarter and fiscal year ended May 31, 2008, both of which are in-line with the Company’s guidance provided in connection with the release of its fiscal third quarter results. The Company also announced that John Soto has resigned from his position as Senior Vice President of Global Sales and has accepted the position of Managing Director with a company in his home country, the United Kingdom.
